BioNTech Comirnaty COVID-19 Vaccine from Japan
Comirnaty is Pfizer's mRNA COVID-19 vaccine in multi-dose vials for retail sale. Its spike protein induction classifies it as an immunological product under HTS 3002.15.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Ultra-low temp vials (-80°C); dose extraction limits (6 doses/vial)
• Lipid nanoparticle composition declaration
• Post-thaw stability data prevents waste classification